Article

Standardising Workforce Cost Estimates Across Australian Jurisdictions: Genomic Testing as a Use Case

2024-04-12

Abstract excerpt

<h4>Introduction</h4> Labour costs are a key driver of healthcare costs and a key component of economic evaluations in healthcare. We undertook the current study to collect information about workforce costs related to clinical genomic testing in Australia, identifying key components of pay scales and contracts, and incorporating these into a matrix to enable modelling of disaggregated costs. <h4>Methods</h4> We un...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cedd9136-a460-50d9-84c1-764117453cee
DOI: 10.1101/2024.04.09.24305541

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Standardising Workforce Cost Estimates Across Australian Jurisdictions: Genomic Testing as a Use CaseDOI 10.1101/2024.04.09.24305541Read

Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in AustraliaSemantic proximity Read

Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023Semantic proximity Read

Uptake of publicly-funded reproductive genetic carrier screening in AustraliaSemantic proximity Read

Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in ScotlandSemantic proximity Read

Cost of Goods Sold Analysis for Manufacturing mRNA-Based Cell and Gene TherapiesSemantic proximity Read

Designing national programs for expanded carrier screening: Results from a discrete-choice experiment in SingaporeSemantic proximity Read

Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencingSemantic proximity Read

Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of <i>Chlamydia trachomatis</i> , <i>Neisseria gonorrhoeae</i> and <i>Trichomonas vaginalis</i>Semantic proximity Read

A cost analysis of a cancer genetic service model in the UKSemantic proximity Read

Return of research results from genomic biobanks: cost mattersSemantic proximity Read

PRECISE-Value: An interactive web application that estimates the value of implementing a clinical decision support system for a pharmacogenomic testing programSemantic proximity Read

An exploratory assessment of the impact of a novel risk assessment test on breast cancer clinic waiting times and workflow: a discrete event simulation modelSemantic proximity Read